Clinical Trials Logo

Anaplastic Ependymoma clinical trials

View clinical trials related to Anaplastic Ependymoma.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04521946 Withdrawn - Malignant Glioma Clinical Trials

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

Start date: January 14, 2021
Phase: Phase 1
Study type: Interventional

This phase I trial investigates the side effects and effectiveness of chemotherapy followed by a donor (allogeneic) stem cell transplant when given to patients with high grade brain cancer. Chemotherapy drugs, such as fludarabine, thiotepa, etoposide, melphalan, and rabbit anti-thymocyte globulin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before a donor stem cell transplant helps kill cancer cells in the body and helps make room in the patient's bone marrow for new blood-forming cells (stem cells) to grow. When the healthy stem cells from a donor are infused into a patient, they may help the patient's bone marrow make more healthy cells and platelets and may help destroy any remaining cancer cells.

NCT ID: NCT00243490 Withdrawn - Clinical trials for Glioblastoma Multiforme

Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors

Start date: n/a
Phase: Phase 2
Study type: Interventional

Primary Objective: - The primary objective is to evaluate the efficacy of photodynamic therapy in the treatment of malignant intracranial tumors. Secondary Objective: - The secondary objective is to evaluate the safety of photodynamic therapy in the treatment of malignant intracranial tumors.